Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s revision history shows a new revision v3.6.4, replacing the previous v3.6.3; this reflects a small maintenance update to the page documentation.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision label was updated to v3.6.3, replacing the previous v3.6.0. This reflects versioning activity rather than content changes.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now indicates that recruitment has ended and includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a revision note (Revision: v3.6.0) and a label adjustment for Intervention/Treatment.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a newer revision of the page content.SummaryDifference0.0%

- Check79 days agoChange DetectedResults have been posted for the study, including ORR and PFS metrics with follow-up details and posting/submission dates. The page now shows the study as completed and adds related documents such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan.SummaryDifference2%

- Check101 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a non-clinical version update of the page display.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.